Sector portfolio · VC firm · Denmark

Novo Holdings' Pharma portfolio

Novo Holdings has backed 17 Pharma startups in rounds we track, $2.8B between them, shown by the stage each has reached. The best-funded is Maplight Therapeutics.

17startups backed
4stages
$2.8Braised between them
Series Bbiggest stage

Novo Holdings's whole portfolioNovo Holdings's profile

Series B

6

Stage not reported

5

Series C and later

4

Series A

2

Segment by segment

Series B

6 startups · $952M raised

  1. CTCrystalys TherapeuticsUnited States$335M
  2. AllakosAllakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.United States$294M
  3. KalVista PharmaceuticalsKalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.United States$125M
  4. Claris BiotherapeuticsClaris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey.United States$124M
  5. InvetxInvetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.United States$61M
  6. BiosyntiaBiosyntia ApS is a Danish industrial biotech company founded in 2012, specializing in bio-based manufacturing processes through prDenmark$14M

Stage not reported

5 startups · $471M raised

  1. Harmony BiosciencesHarmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.United States$248M
  2. 21st.BIO21st.BIO is a biotechnology company based in Copenhagen, Denmark, founded in 2020.Denmark$97M
  3. Thesan PharmaceuticalsThesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.United States$65M
  4. Spruce BiosciencesSpruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.United States$60M
  5. Muna TherapeuticsMuna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.Denmark$1.0M

Series C and later

4 startups · $1.2B raised

  1. MapLight TherapeuticsMapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.United States$523M
  2. OMass TherapeuticsOMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule meUnited Kingdom$442M
  3. Cyteir TherapeuticsCyteir is developing the next generation of synthetic lethal therapies to treat cancer.United States$126M
  4. Avalyn PharmaAvalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.United States$100M

Series A

2 startups · $151M raised

  1. Augustine TherapeuticsAugustine Therapeutics is a Belgian biotechnology company founded in 2019 and based in Leuven.Belgium$84M
  2. Rondo TherapeuticsRondo Therapeutics is a clinical-stage biopharmaceutical company based in Hayward, California, focused on developing next-generatiUnited States$67M

How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Novo Holdings as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioNovo Holdings' Biotech portfolio88 startups · $9.4BPortfolio mapNovo Holdings portfolio map123 startups · $21BCo-investorsWho invests with Novo Holdings87 co-investorsInvestments abroadNovo Holdings' investments in the United States64 startups · $11BSector portfolioSeed Capital's AI portfolio25 startups · $238MSector portfolioByFounders' AI portfolio20 startups · $562M

Raising from investors like Novo Holdings?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps